Fanaei Pirlar, R.; Wagemans, J.; Kunisch, F.; Lavigne, R.; Trampuz, A.; Gonzalez Moreno, M.
Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent. Pharmaceutics 2022, 14, 2216.
https://doi.org/10.3390/pharmaceutics14102216
AMA Style
Fanaei Pirlar R, Wagemans J, Kunisch F, Lavigne R, Trampuz A, Gonzalez Moreno M.
Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent. Pharmaceutics. 2022; 14(10):2216.
https://doi.org/10.3390/pharmaceutics14102216
Chicago/Turabian Style
Fanaei Pirlar, Rima, Jeroen Wagemans, Fabian Kunisch, Rob Lavigne, Andrej Trampuz, and Mercedes Gonzalez Moreno.
2022. "Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent" Pharmaceutics 14, no. 10: 2216.
https://doi.org/10.3390/pharmaceutics14102216
APA Style
Fanaei Pirlar, R., Wagemans, J., Kunisch, F., Lavigne, R., Trampuz, A., & Gonzalez Moreno, M.
(2022). Novel Stenotrophomonas maltophilia Bacteriophage as Potential Therapeutic Agent. Pharmaceutics, 14(10), 2216.
https://doi.org/10.3390/pharmaceutics14102216